SCN2A and epilepsy: Analyses in heterologous expression systems of several disease-associated SCN2A variants found that ASD-associated mutations generally cause channel loss-of-function effects (often because of protein truncation variants), while epilepsy-associated mutations reveal various biophysical gain-of-function effects (increased Na+ influx) (10).